Abstract

Why Considering the Impact of Cartridge Architecture Matters for the Final Product Cost of Goods

Leanna M Levine, Founder & President, ALine, Inc.

As microfluidics-based products mature and move toward the consumer market, the drive toward a lower cost of goods for the instrument, in addition to a low-cost consumable, requires consideration of the overall cartridge architecture and the instrument interface early in the development program. For example, choices in the valve design and actuation method can lead to the instrument, rather than the assay protocol, driving the cartridge design.  In this presentation, we will review examples and strategies that have been implemented in development programs, and provide context on the impact of different choices on the system, including impact on the size of the microfluidics-based consumable, and overall system  complexity.